AbbVie said on Monday its treatment for a group of blood cancers failed to meet the main goal of significantly improving the ...

A programme to evaluate a blood test for early signs of pancreatic cancer has started to recruit volunteers. The Safe-D study ...

Scientists have developed a “highly sensitive” blood test that could detect signs of cancerous tumours years before the first ...

Researchers at Johns Hopkins University have discovered that cancer can be detected in the bloodstream a full three years ...

A Johns Hopkins University study shows that a simple blood test may detect cancer long before symptoms emerge, potentially ...

“These results demonstrate that it is possible to detect circulating tumor DNA more than three years prior to clinical ...

Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...

A father-of-three who was initially told his rib and back pain was likely caused by a pulled muscle was left in “complete ...

‘Three years earlier provides time for intervention,’ the lead researcher says of the early detection test. Mr. Curl covered ...

A new hereditary condition has been discovered that affects patients' ability to repair DNA—leaving them both at greater risk ...

New blood tests promise to detect malignancies before they’ve spread. But proving that these tests actually improve outcomes ...

AbbVie (ABBV) stock in focus after a Phase 3 trial setback for leukemia therapy venetoclax marketed with Roche (RHHBY) in ...